SCHEMBL7984751

SCHEMBL7984751

NC(=O)c1c(NC(=O)c2ccccc2)ncn1Cc1ccccc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 3/20 0.46
P2RY14 Q15391 1/20 0.44
VNN1 O95497 1/20 0.44
HSD17B13 Q7Z5P4 1/20 0.43
PPARG P37231 1/20 0.43
PDE4A P27815 4/20 0.42
PDE4B Q07343 4/20 0.42
PDE4C Q08493 4/20 0.42
PDE4D Q08499 4/20 0.42
TP53 P04637 3/20 0.42
PDE5A O76074 2/20 0.41
PDE1A P54750 2/20 0.41
PDE1B Q01064 2/20 0.41
PDE3B Q13370 2/20 0.41
PDE1C Q14123 2/20 0.41
PDE3A Q14432 2/20 0.41
KDM4A O75164 1/20 0.41
KDM5A P29375 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
KDM5B Q9UGL1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974172 0.90 HDAC3 (0.44) VNN1HSD17B13NPC1RAB9ALMNA
SCHEMBL7987920 0.89 TP53 (0.47) HSD17B13PDE4APDE4BPDE4CPDE4D
SCHEMBL7991817 0.86 KDM4E (0.51) P2RY14TP53MAPTCYP1A2CYP3A4
SCHEMBL7985416 0.86 LMNA (0.50) P2RY14TP53KDM4CMEN1KMT2A
SCHEMBL7975241 0.84 GAA (0.50) NTRK1HSD17B13NPC1RAB9ALMNA
SCHEMBL7987938 0.84 KDM4E (0.44) PPARGPDE4APDE4BPDE4CPDE4D
SCHEMBL7973841 0.84 RAB9A (0.47) NTRK1P2RY14HSD17B13MEN1KMT2A
SCHEMBL7985255 0.82 ALDH1A1 (0.51) PPARGMEN1KMT2AMAPTNPC1
SCHEMBL7988506 0.81 NTRK1 (0.48) NTRK1P2RY14HSD17B13PPARGKDM4C
SCHEMBL7974516 0.81 HTT (0.43) KMT2AMAPTCYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed